Paracetamol Vir

Paracetamol, the active ingredient in Paracetamol Vir, is an analgesic, antipyretic presented as an oral tablet for oral use. It treats mild to moderate pain and reduces fever in adults and children when appropriate.

GNH USA supplies Paracetamol Vir as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Paracetamol Vir belongs to the analgesic and antipyretic drug class and acts on pain and temperature regulation pathways. - Pain relief: reduces mild to moderate pain such as headache, toothache, or musculoskeletal discomfort. - Fever reduction: lowers elevated body temperature associated with infections or other causes. - Post‑operative discomfort: helps manage pain after minor surgical procedures.

Paracetamol is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild stomach upset may be experienced. - Headache: occasional transient headache. - Rash: mild skin irritation or rash. - Dizziness: brief episodes of light‑headedness.

Serious or Rare Side Effects: - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Liver toxicity: especially with overdose or chronic high‑dose use. - Blood disorders: including thrombocytopenia or neutropenia. - Anaphylaxis: rare but potentially life‑threatening allergic response.

Paracetamol should be used with caution in specific populations and conditions. - Dosage adjustment: required in patients with liver impairment. - Alcohol consumption: avoid excessive alcohol while using. - Pregnancy: use only if clearly needed after medical advice. - Drug interactions: review concomitant medications for potential interactions. - Overdose risk: seek immediate medical attention if the recommended dose is exceeded. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Paracetamol can interact with several medicines, necessitating careful review.

Major Interactions (Avoid): - Warfarin: may increase bleeding risk. - Isoniazid: combined hepatotoxic potential. - Carbamazepine: induces metabolism, reducing efficacy. - Phenytoin: may alter drug levels.

Moderate Interactions (Monitor Closely): - Other hepatotoxic agents (e.g., valproic acid): monitor liver function. - CYP450 inhibitors (e.g., fluconazole): may increase plasma concentrations. - Oral contraceptives: may slightly reduce contraceptive effectiveness.